Basic Stats
| CIK | 1735803 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Apria Inc
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| February 8, 2023 |
APR / Apria, Inc. / AMERICAN CENTURY INVESTMENT MANAGEMENT INC - SC 13G/A Passive Investment SC 13G/A 1 apriainc13g-a1.htm SC 13G/A United States Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* APRIA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03836A101 (CUSIP Number) DECEMBER 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 6, 2023 |
APR / Apria, Inc. / VICTORY CAPITAL MANAGEMENT INC Passive Investment SC 13G/A 1 apria13ga1123122.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ( Amendment No. 1)* Apria Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 03836A101 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| April 8, 2022 |
APR / Apria, Inc. / ALGER ASSOCIATES INC - APRIA, INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Apria, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 03836A101 (CUSIP Number) March 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fi |
|
| April 8, 2022 |
15-12B 1 d343965d1512b.htm 15-12B As filed with the Securities and Exchange Commission on April 8, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES ACT OF 1934. Comm |
|
| March 29, 2022 |
Amended and Restated Bylaws of Apria, Inc. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF APRIA, INC. A Delaware Corporation (Adopted as of March 29, 2022) ARTICLE I OFFICES Section 1. Registered Office. The registered office of Apria, Inc. (the ?Corporation?) in the State of Delaware shall be located at 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808. The name of the Corporation?s registered agent at such address shall b |
|
| March 29, 2022 |
Second Amended and Restated Certificate of Incorporation of Apria, Inc. Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF APRIA, INC. (a Delaware corporation) ARTICLE ONE The name of the company is Apria, Inc. (the ?Company?). ARTICLE TWO The registered office of the Company in the State of Delaware is located at 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808, and the name of the registered agent whose office address will b |
|
| March 29, 2022 |
As filed with the Securities and Exchange Commission on March 29, 2022 As filed with the Securities and Exchange Commission on March 29, 2022 Registration No. |
|
| March 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 29, 2022 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission file number: 001-40053 A |
|
| March 24, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 24, 2022 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 14, 2022 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 14, 2022 |
DEFA14A 1 d222023ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| March 10, 2022 |
APR / Apria, Inc. / GLAZER CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Apria, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 03836A101 (CUSIP Number) February 28, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 1, 2022 |
Subsidiaries of the Registrant* ? Exhibit 21.1 Subsidiaries of Apria, Inc. (as of March 1, 2022) Name Jurisdiction of Incorporation or Organization Apria Healthcare Group LLC Delaware Apria Healthcare LLC Delaware Apria Holdco LLC Delaware CPAP Sleep Store LLC Delaware DMEhub LLC Delaware Healthy Living Home Medical LLC Delaware Lofta ? California ? ? |
|
| February 28, 2022 |
Apria Announces Financial Results for Fourth Quarter and Full Year 2021 ? ? Exhibit 99.1 Apria Announces Financial Results for Fourth Quarter and Full Year 2021 Indianapolis, Indiana, February 28, 2022 - Apria, Inc. (the ?Company? or ?Apria?) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously an |
|
| February 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of Earliest Event Reported): February 28, 2022 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001-40053 (Commission File N |
|
| February 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| February 22, 2022 |
DEFM14A 1 d271832ddefm14a.htm DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| February 22, 2022 |
DEFA14A 1 d299481ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| February 14, 2022 |
APR / Apria, Inc. / ALGER ASSOCIATES INC - APRIA, INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Apria, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 03836A101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 11, 2022 |
Exhibit 1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the ?Exchange Act?) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Apria, Inc. |
|
| February 11, 2022 |
APR / Apria, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| February 11, 2022 |
APR / Apria, Inc. / Blackstone Holdings III L.P. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Apria, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 03836A101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 8, 2022 |
DEFA14A 1 d277450ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| February 7, 2022 |
Calculation of Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE Table 1 ? Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee Rate Amount of Filing Fee Fees to Be Paid $1,452,172,696. |
|
| February 7, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi |
|
| February 4, 2022 |
APR / Apria, Inc. / AMERICAN CENTURY INVESTMENT MANAGEMENT INC - SC 13G Passive Investment United States Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* APRIA, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 03836A101 (CUSIP Number) DECEMBER 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 2, 2022 |
APR / Apria, Inc. / VICTORY CAPITAL MANAGEMENT INC Passive Investment SC 13G 1 apria13g123121.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ( Amendment No. )* Apria Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 03836A101 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| January 21, 2022 |
DEFA14A 1 d287650ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| January 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 10, 2022 |
DEFA14A 1 d272724ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| January 10, 2022 |
Exhibit 99.1 OWENS & MINOR, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE APRIA, INC. Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth RICHMOND, Va. and INDIANAPOLIS ?(BUSINESS WIRE) ? Jan. 10, 2022? Owens & Minor, Inc. (?Owens & Minor?) (NYSE: OMI) and Apria, In |
|
| January 10, 2022 |
DEFA14A 1 d487820ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 7, 2022 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| January 10, 2022 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among OWENS & MINOR, INC., STONEOAK MERGER SUB INC. and APRIA, INC. Dated as of January 7, 2022 TABLE OF CONTENTS Page ARTICLE I THE TRANSACTIONS SECTION 1.01 The Merger 2 SECTION 1.02 Closing 2 SECTION 1.03 Effective Time 2 SECTION 1.04 Effects of the Merger 2 SECTION 1.05 Certificate of Incorporation and Bylaws of the Surviving Co |
|
| November 12, 2021 |
4,500,000 Shares Apria, Inc. Common Stock Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-260866 4,500,000 Shares Apria, Inc. Common Stock The selling stockholders named in this prospectus are offering 4,500,000 shares of common stock of Apria, Inc. We will not receive any proceeds from the sale of shares of common stock by the selling stockholders. Our shares of common stock are listed on The Nasdaq Stock Market L |
|
| November 8, 2021 |
Form of Underwriting Agreement Exhibit 1.1 Apria, Inc. Common Stock, par value $0.01 per share Underwriting Agreement November [•], 2021 Citigroup Global Markets Inc. Goldman Sachs & Co. LLC As representatives of the several Underwriters named in Schedule II hereto c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Ladies and Gentlemen |
|
| November 8, 2021 |
As filed with the Securities and Exchange Commission on November 8, 2021. Table of Contents As filed with the Securities and Exchange Commission on November 8, 2021. |
|
| November 8, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] VIA EDGAR November 8, 2021 Re: Acceleration Request for Apria, Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 205 |
|
| November 5, 2021 |
? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? (Mark One) ?QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended September 30, 2021 ? or ? ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ? EXCHANGE ACT OF 1934 ? For the transition period from to ? Commission File Number: |
|
| November 4, 2021 |
Apria Announces Financial Results for Third Quarter 2021 ? ? Exhibit 99.1 ? Apria Announces Financial Results for Third Quarter 2021 Indianapolis, Indiana, November 4, 2021 - Apria, Inc. (the ?Company? or ?Apria?) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the third quarter ended September 30, 2021. ?We delivered solid third quarter 2021 finan |
|
| November 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of Earliest Event Reported): November 4, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001-40053 (Commission File Nu |
|
| October 7, 2021 |
? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of Earliest Event Reported): October 4, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001-40053 (Commission File Num |
|
| September 3, 2021 |
Table of Contents Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. As confidentially submitted to the Securities and Exchange Commission on September 3, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION S |
|
| August 6, 2021 |
Form of Performance Stock Unit Agreement under the Apria, Inc. 2021 Omnibus Incentive Plan ? Exhibit 10.3 PERFORMANCE STOCK UNIT GRANT NOTICE UNDER THE APRIA, INC. 2021 OMNIBUS INCENTIVE PLAN PERFORMANCE-BASED VESTING AWARD Apria, Inc. (the ?Company?), pursuant to its 2021 Omnibus Incentive Plan, as it may be amended and/or restated from time to time (the ?Plan?), hereby grants to the Participant set forth below, the number of performance-based Restricted Stock Units (?Performance Stock |
|
| August 6, 2021 |
Exhibit 10.1 RESTRICTED STOCK UNIT GRANT NOTICE UNDER THE APRIA, INC. 2021 OMNIBUS INCENTIVE PLAN (Non-Employee Director Award) Apria, Inc. (the ?Company?), pursuant to its 2021 Omnibus Incentive Plan, as it may be amended and restated from time to time (the ?Plan?), hereby grants to the Participant set forth below, the number of Restricted Stock Units set forth below. The Restricted Stock Units a |
|
| August 6, 2021 |
? Exhibit 10.2 RESTRICTED STOCK UNIT GRANT NOTICE UNDER THE APRIA, INC. 2021 OMNIBUS INCENTIVE PLAN TIME-BASED VESTING AWARD Apria, Inc. (the ?Company?), pursuant to its 2021 Omnibus Incentive Plan, as it may be amended and/or restated from time to time (the ?Plan?), hereby grants to the Participant set forth below, the number of Restricted Stock Units set forth below. The Restricted Stock Units a |
|
| August 6, 2021 |
? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? (Mark One) ?QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended June 30, 2021 ? or ? ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ? EXCHANGE ACT OF 1934 ? For the transition period from to ? Commission File Number: 001- |
|
| August 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of Earliest Event Reported): August 5, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001-40053 (Commission File Numb |
|
| August 5, 2021 |
APR / Apria, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| August 5, 2021 |
Apria Announces Financial Results for Second Quarter 2021 ? ? Exhibit 99.1 Apria Announces Financial Results for Second Quarter 2021 Indianapolis, Indiana, August 5, 2021 - Apria, Inc. (the ?Company? or ?Apria?) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the second quarter ended June 30, 2021. ?We delivered another strong quarter as our second |
|
| June 10, 2021 |
4,500,000 Shares Apria, Inc. Common Stock Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-256863 4,500,000 Shares Apria, Inc. Common Stock The selling stockholders named in this prospectus are offering 4,500,000 shares of common stock of Apria, Inc. We will not receive any proceeds from the sale of shares of common stock by the selling stockholders. Our shares of common stock are listed on the Nasdaq Global Select |
|
| June 7, 2021 |
As filed with the Securities and Exchange Commission on June 7, 2021. Table of Contents As filed with the Securities and Exchange Commission on June 7, 2021. |
|
| June 7, 2021 |
Form of Underwriting Agreement* EX-1.1 2 d182907dex11.htm EX-1.1 Exhibit 1.1 Apria, Inc. Common Stock, par value $0.01 per share Underwriting Agreement June [•], 2021 Citigroup Global Markets Inc. Goldman Sachs & Co. LLC As representatives of the several Underwriters named in Schedule II hereto c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Goldman Sachs & Co. LLC 200 West Street New York, New Yo |
|
| June 7, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] VIA EDGAR June 7, 2021 Re: Acceleration Request for Apria, Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 A |
|
| May 14, 2021 |
? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? (Mark One) ?QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended March 31, 2021 ? or ? ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ? EXCHANGE ACT OF 1934 ? For the transition period from to ? Commission File Number: 001 |
|
| May 13, 2021 |
Apria Announces Financial Results for First Quarter 2021 Apria Announces Financial Results for First Quarter 2021 Indianapolis, Indiana, May 13, 2021 - Apria, Inc. |
|
| May 13, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ? FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of Earliest Event Reported): May 13, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) ? ? ? ? Delaware (State or Other Jurisdiction of Incorporation) 001-40053 (Commission File Number |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 4, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| April 30, 2021 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. As confidentially submitted to the Securities and Exchange Commission on April 30, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES |
|
| March 31, 2021 |
Exhibit 4.1 DESCRIPTION OF REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 ? Apria, Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: its common stock, par value $0.01 per share. References herein to ?we,? ?us,? ?our? and ?Company? refer to Apria, Inc. and not to any of its subsidiaries. |
|
| March 31, 2021 |
Subsidiaries of the Registrant* ? Exhibit 21.1 Subsidiaries of Apria, Inc. (as of March 30, 2021) Name Jurisdiction of Incorporation or Organization Apria Healthcare Group LLC Delaware Apria Healthcare LLC Delaware Apria Holdco LLC Delaware CPAP Sleep Store LLC Delaware DMEhub LLC Delaware Healthy Living Home Medical LLC Delaware ? ? |
|
| March 31, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 30, 2021 |
Apria Announces Financial Results for Fourth Quarter and Full Year 2020 EX-99.1 Exhibit 99.1 Apria Announces Financial Results for Fourth Quarter and Full Year 2020 Indianapolis, Indiana, March 30, 2021 — Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the U.S., announced today financial results for the fourth quarter and full year ended December 31, 2020. “We made great strides d |
|
| March 30, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 30, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| February 16, 2021 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT by and between APRIA, INC. and the other parties hereto Dated as of February 16, 2021 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 SECTION 1.1 Certain Definitions 1 SECTION 1.2 Other Definitional Provisions; Interpretation 5 ARTICLE II REGISTRATION RIGHTS 6 SECTION 2.1 Piggyback Rights 6 SECTION 2.2 Demand Registration 8 SECTION 2.3 Registration Procedu |
|
| February 16, 2021 |
Exhibit 10.1 STOCKHOLDERS AGREEMENT DATED AS OF FEBRUARY 16, 2021 AMONG APRIA, INC. AND THE OTHER PARTIES HERETO Table of Contents Page ARTICLE I. INTRODUCTORY MATTERS 1 1.1 Defined Terms 1 1.2 Construction 4 ARTICLE II. CORPORATE GOVERNANCE MATTERS 5 2.1 Election of Directors 5 2.2 Compensation 6 2.3 Other Rights of Stockholder Designees 6 ARTICLE III. INFORMATION; VCOC 7 3.1 Books and Records; A |
|
| February 16, 2021 |
Amended and Restated Certificate of Incorporation of the Registrant Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF APRIA, INC. The present name of the corporation is Apria, Inc. (the ?Corporation?). The Corporation was incorporated under the name ?Apria, Inc.? by the filing of its original certificate of incorporation (the ?Original Certificate of Incorporation?) with the Secretary of State of the State of Delaware on March 22, 2018. This Amended |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 10, 2021 Apria, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-40053 82-4937641 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| February 16, 2021 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF APRIA, INC. ARTICLE I Offices SECTION 1.01 Registered Office. The registered office and registered agent of Apria, Inc. (the ?Corporation?) in the State of Delaware shall be as set forth in the Restated Certificate of Incorporation (as defined below). The Corporation may also have offices in such other places in the United States or elsewhere as the Board |
|
| February 12, 2021 |
Apria, Inc. 2021 Omnibus Incentive Plan Exhibit 4.3 APRIA, INC. 2021 OMNIBUS INCENTIVE PLAN 1. Purpose. The purpose of the Apria, Inc. 2021 Omnibus Incentive Plan is to provide a means through which the Company and the other members of the Company Group may attract and retain key personnel, and to provide a means whereby directors, officers, employees, consultants, and advisors of the Company and the other members of the Company Group c |
|
| February 12, 2021 |
Exhibit 4.4 APRIA, INC. 2015 STOCK PLAN 1. Purpose. The purpose of the Apria, Inc. 2015 Stock Plan is to provide a means through which Apria, Inc. (the ?Company?) and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors (and prospective directors, officers, employees, consultants and advisors) of the Company and |
|
| February 12, 2021 |
7,500,000 Shares Apria, Inc. Common Stock Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-252146 Prospectus 7,500,000 Shares Apria, Inc. Common Stock This is the initial public offering of shares of common stock of Apria, Inc. No public market currently exists for our common stock. The selling stockholders are offering 7,500,000 shares of common stock. We will not receive any proceeds from the sale of shares of com |
|
| February 12, 2021 |
As filed with the Securities and Exchange Commission on February 12, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Apria, Inc. (Exact name of registrant as specified in its charter) Delaware 82-4937641 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer |
|
| February 11, 2021 |
8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Apria, Inc. (Exact name of registrant as specified in its charter) Delaware 82-4937641 (State of incorporation or organization) (I.R.S. Employer Identification No.) 7353 Company Drive, India |
|
| February 9, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER (212) 455-7614 E-MAIL ADDRESS [email protected] VIA EDGAR February 9, 2021 Re: Acceleration Request for Apria, Inc. Registration Statement on Form S-1 (File No. 333-252146) Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E |
|
| February 9, 2021 |
February 9, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| February 9, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] February 9, 2021 VIA EDGAR Re: Apria, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed February 3, 2021 File No. 333-252146 Abby Adams, Esq. Division of Corporation Finance Securities and Excha |
|
| February 9, 2021 |
EX-10.36 Exhibit 10.36 MASTER REORGANIZATION AGREEMENT dated as of February , 2021 by and among each of the Parties set forth in the Preamble hereto TABLE OF CONTENTS Page ARTICLE I THE MERGERSUB AND APRIA HEALTHCARE MERGER 2 1.1 Merger 2 ARTICLE II THE APRIA HEALTHCARE CONVERSION 3 2.1 Conversion 3 ARTICLE III EXCHANGE OF APRIA HOLDINGS INTERESTS FOR SHARES OF PUBCO 4 ARTICLE IV ADMISSION OF AS |
|
| February 9, 2021 |
February 9, 2021 VIA EDGAR Re: Apria, Inc. Registration Statement on Form S-1 File No. 333-252146 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Abby Adams, Esq. Laura Crotty, Esq. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apria, Inc. (the ?Company?) hereby requests that the effe |
|
| February 9, 2021 |
S-1/A Table of Contents As filed with the Securities and Exchange Commission on February 9, 2021. |
|
| February 3, 2021 |
S-1/A Table of Contents As filed with the Securities and Exchange Commission on February 3, 2021. |
|
| February 3, 2021 |
Form of Underwriting Agreement Exhibit 1.1 Apria, Inc. Common Stock, par value $0.01 per share Underwriting Agreement [●], 2021 Citigroup Global Markets Inc. Goldman Sachs & Co. LLC As representatives of the several Underwriters named in Schedule II hereto c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Ladies and Gentlemen: Certain |
|
| February 3, 2021 |
Exhibit 10.26 OMNIBUS AMENDMENT TO THE STOCK APPRECIATION RIGHTS AGREEMENT under the APRIA, INC. 2015 STOCK PLAN THIS OMNIBUS AMENDMENT (this “Amendment”), dated as of February [•], 2021, amends each Stock Appreciation Rights Agreement (each, as amended from time to time, an “Agreement”) outstanding as of the date hereof under the Plan (as defined below) and is entered into by Apria, Inc., a Delaw |
|
| February 3, 2021 |
Form of Apria, Inc. 2021 Omnibus Incentive Plan EX-10.3 Exhibit 10.3 APRIA, INC. 2021 OMNIBUS INCENTIVE PLAN 1. Purpose. The purpose of the Apria, Inc. 2021 Omnibus Incentive Plan is to provide a means through which the Company and the other members of the Company Group may attract and retain key personnel, and to provide a means whereby directors, officers, employees, consultants, and advisors of the Company and the other members of the Compan |
|
| February 3, 2021 |
Form of Indemnification Agreement Exhibit 10.35 INDEMNIFICATION AGREEMENT This Indemnification Agreement is effective as of [ ], 2021 (this “Agreement”) and is between Apria, Inc., a Delaware corporation (the “Company”), and the undersigned director/officer of the Company (the “Indemnitee”). Background The Company believes that, in order to attract and retain highly competent persons to serve as directors or in other capacities, i |
|
| February 3, 2021 |
EX-3.1 3 d62545dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF APRIA, INC. The present name of the corporation is Apria, Inc. (the “Corporation”). The Corporation was incorporated under the name “Apria, Inc.” by the filing of its original certificate of incorporation (the “Original Certificate of Incorporation”) with the Secretary of State of the State of Delaware |
|
| February 3, 2021 |
EX-10.4 Exhibit 10.4 RESTRICTED STOCK UNIT GRANT NOTICE UNDER THE APRIA, INC. 2021 OMNIBUS INCENTIVE PLAN TIME-BASED VESTING AWARD Apria, Inc. (the “Company”), pursuant to its 2021 Omnibus Incentive Plan, as it may be amended and restated from time to time (the “Plan”), hereby grants to the Participant set forth below, the number of Restricted Stock Units set forth below in full satisfaction of th |
|
| February 3, 2021 |
Exhibit 10.33 SECOND AMENDED AND RESTATED APRIA, INC. LONG-TERM INCENTIVE PLAN (2019 – 2021 With Successive Annual Extension Options) 1. Purpose. The purpose of the Second Amended and Restated Apria, Inc. Long-Term Incentive Plan (the “Plan”), as documented herein, is to provide long-term incentive compensation to certain senior and executive officers of the Company in order to incentivize them to |
|
| February 3, 2021 |
Form of Stock Appreciation Rights Agreement under the Apria, Inc. 2015 Stock Plan EX-10.24 Exhibit 10.24 STOCK APPRECIATION RIGHTS AGREEMENT under the APRIA HEALTHCARE GROUP INC. 2015 STOCK PLAN THIS AGREEMENT (the “Agreement”) by and between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and the individual named on the signature page hereto (the “Participant”) is made as of the date set forth on such signature page. Capitalized terms not otherwise defined |
|
| February 3, 2021 |
EX-21.1 12 d62545dex211.htm EX-21.1 Exhibit 21.1 Subsidiaries of Apria, Inc. Upon the consummation of this offering, the following entities will become subsidiaries of Apria, Inc. Name of Subsidiary Jurisdiction of Incorporation or Organization Apria Holdco LLC Delaware Apria Healthcare Group LLC Delaware DMEhub LLC Delaware Apria Healthcare LLC Delaware CPAP Sleep Store LLC Delaware Healthy Livin |
|
| February 3, 2021 |
Form of Apria, Inc. 2015 Stock Plan EX-10.25 Exhibit 10.25 APRIA, INC. 2015 STOCK PLAN 1. Purpose. The purpose of the Apria, Inc. 2015 Stock Plan is to provide a means through which Apria, Inc. (the “Company”) and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors (and prospective directors, officers, employees, consultants and advisors) of the |
|
| January 29, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] January 29, 2021 VIA EDGAR Re: Apria, Inc. Registration Statement on Form S-1 Filed January 15, 2021 Response Dated January 25, 2021 File No. 333-252146 Abby Adams, Esq. Division of Corporation Finance Securit |
|
| January 29, 2021 |
begin 644 filename2 M)5!$1BTQ+C8-)>+CS],-"C$@,"!O8FH*/#PO365T861A=&$@,B P(%(O4&%G M97,@,R P(%(O5'EP92]#871A;&]G/CX*96YD;V)J"C(@,"!O8FH*/#PO3&5N M9W1H(#,R-C8O4W5B='EP92]834PO5'EP92]-971A9&%T83X^G)E4WI. |
|
| January 25, 2021 |
begin 644 filename2 M)5!$1BTQ+C<-)>+CS],-"C$@,"!O8FH*/#PO365T861A=&$@,B P(%(O4&%G M97,@,R P(%(O4W1R=6-T5')E95)O;W0@-2 P(%(O5'EP92]#871A;&]G/CX* M96YD;V)J"C(@,"!O8FH*/#PO3&5N9W1H(#,R-C8O4W5B='EP92]834PO5'EP M92]-971A9&%T83X^G)E4WI. |
|
| January 25, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] January 25, 2021 VIA EDGAR Re: Apria, Inc. Registration Statement on Form S-1 Filed January 15, 2021 File No. 333-252146 Abby Adams, Esq. Division of Corporation Finance Securities and Exchange Commission 100 |
|
| January 15, 2021 |
EX-10.20 22 d62545dex1020.htm EX-10.20 Exhibit 10.20 December 1, 2020 Mark E. Litkovitz [redacted] Re: Amendment of Executive Vice President Agreement Dear Mark E. Litkovitz: This letter confirms the amendment, as set forth below, of your Executive Vice President Severance Agreement, dated April 30, 2014, with Apria Healthcare Group Inc. (the “Agreement”). In the event that you become entitled to |
|
| January 15, 2021 |
Form of Stockholders Agreement** Exhibit 10.1 STOCKHOLDERS AGREEMENT DATED AS OF [ ], [ ] AMONG APRIA, INC. AND THE OTHER PARTIES HERETO Table of Contents Page ARTICLE I. INTRODUCTORY MATTERS 1 1.1 Defined Terms 1 1.2 Construction 4 ARTICLE II. CORPORATE GOVERNANCE MATTERS 5 2.1 Election of Directors 5 2.2 Compensation 6 2.3 Other Rights of Stockholder Designees 6 ARTICLE III. INFORMATION; VCOC 7 3.1 Books and Records; Access 7 3 |
|
| January 15, 2021 |
EX-10.31 Exhibit 10.31 EXECUTION COPY This TRANSACTION AND MANAGEMENT FEE AGREEMENT (this “Agreement”) is dated as of October 28, 2008 and is between Sky Merger Sub Corporation, a Delaware corporation (together with its successors, the “Company”), and Blackstone Management Partners V L.L.C., a Delaware limited liability company (“BMP”). BACKGROUND 1. The Company has entered into an Agreement and P |
|
| January 15, 2021 |
EX-10.19 Exhibit 10.19 EXECUTIVE VICE PRESIDENT SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 30th day of April, 2014, between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and Mark E. Litkovitz (the “Executive”). RECITALS A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s |
|
| January 15, 2021 |
EX-10.7 Exhibit 10.7 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”) is entered into by and between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and Daniel J. Starck (the “Executive”) as of March 14, 2012 (the “Effective Date”). RECITALS A. It is the desire of the Company to retain the services of the Executive and to recognize the Exec |
|
| January 15, 2021 |
Amended and Restated Bylaws of the Registrant EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF APRIA, INC. ARTICLE I Offices SECTION 1.01 Registered Office. The registered office and registered agent of Apria, Inc. (the “Corporation”) in the State of Delaware shall be as set forth in the Restated Certificate of Incorporation (as defined below). The Corporation may also have offices in such other places in the United States or elsewhere as th |
|
| January 15, 2021 |
Bonus Letter Agreement from Apria Healthcare Group Inc. to Debra L. Morris, dated July 24, 2018 Exhibit 10.12 Execution Version July 24, 2018 Ms. Debra Morris Dear Debby: I am pleased to inform you that you have been selected to receive a transaction-related bonus, as described below. Your continued hard work and dedication is very important to Apria Healthcare Group Inc. (the “Company”) and the Company would like to thank you. This letter agreement amends, restates and supersedes, in full, |
|
| January 15, 2021 |
Exhibit 10.10 EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 11th day of March, 2013, between Apria Healthcare, Inc., a Delaware corporation (the “Company”), and Debra L. Morris (the “Executive”). RECITALS A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s contribution to the Company. B |
|
| January 15, 2021 |
Exhibit 10.18 November 15, 2020 Robert P. Walker Re: Amendment of Executive Severance Agreement Dear Robert: This letter confirms the amendment, as set forth below, of your Executive Severance Agreement, dated April 1, 2013, with Apria Healthcare Group Inc. (the “Agreement”). This letter supersedes that certain letter agreement between you and Apria Healthcare LLC, dated June 27, 2018, in its enti |
|
| January 15, 2021 |
EX-10.29 Exhibit 10.29 AMENDMENT NO. 2 TO THE APRIA HEALTHCARE GROUP INC. DEFERRED COMPENSATION PLAN The Apria Healthcare Group Inc. Deferred Compensation Plan (“the Plan”) is hereby amended in the following respects, effective as of January 1, 2019: 1. Section 1.4 of the Plan is hereby amended in its entirety to read as follows: “Annual Deferral Amount” shall mean that portion of a Participant’s |
|
| January 15, 2021 |
EX-10.30 Exhibit 10.30 AMENDMENT NO. 3 TO THE APRIA HEALTHCARE GROUP INC. DEFERRED COMPENSATION PLAN The Apria Healthcare Group Inc. Deferred Compensation Plan (“the Plan”) is, by way of clarification of the administration of the Plan, hereby amended in the following respects, effective as of January 1, 2020: 1. Section 12.1 of the Plan is hereby amended in its entirety to read as follows: 12.1 Co |
|
| January 15, 2021 |
EX-10.32 Exhibit 10.32 December 1, 2020 Mr. Raoul Smyth Re: Retirement Letter Dear Raoul: This letter agreement reflects the mutually agreed terms of your retirement from Apria Healthcare LLC (the “Company”). Your hard work and dedication are very important to the Company and the Company would like to thank you for your service. You will continue in your current position as Executive Vice Presiden |
|
| January 15, 2021 |
Exhibit 10.8 December 5, 2012 Daniel J. Starck [Redacted] Re: Amendment of Executive Employment Agreement Dear Dan: This letter confirms the amendment, as set forth below, of your Executive Employment Agreement, dated 3/14/2012, with Apria Healthcare Group Inc. (the “Severance Agreement”). In the event that you become entitled to severance pay pursuant to Section 4(a) of the Severance Agreement an |
|
| January 15, 2021 |
Form of Underwriting Agreement Exhibit 1.1 Apria, Inc. Common Stock, par value $0.01 per share Underwriting Agreement [•], 2021 Citigroup Global Markets Inc. Goldman Sachs & Co. LLC As representatives of the several Underwriters named in Schedule II hereto c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Ladies and Gentlemen: Apria, |
|
| January 15, 2021 |
EX-10.22 Exhibit 10.22 INDEPENDENT DIRECTOR AGREEMENT This INDEPENDENT DIRECTOR AGREEMENT is dated August 15, 2019 (this “Agreement”) by and between APRIA HEALTHCARE GROUP INC., a Delaware corporation (the “Company”), and LYNN SHAPIRO SNYDER, an individual resident of the State of Maryland (the “Director”). WHEREAS, it is anticipated that the Director will be appointed to the Board of Directors of |
|
| January 15, 2021 |
EX-10.14 Exhibit 10.14 EXECUTION VERSION December 28, 2020 Ms. Debra Morris Re: Your Apria Healthcare Group Inc. (“AHG”) Restricted Stock Unit (“RSU”) grant pursuant to letter dated July 24, 2018, as amended by the letter dated December 20, 2019 (as amended, the “Grant Letter”) Dear Debby: The purpose of this letter is to evidence our agreement to adjust the terms of your Grant Letter to compensat |
|
| January 15, 2021 |
As filed with the Securities and Exchange Commission on January 15, 2021. S-1 Table of Contents As filed with the Securities and Exchange Commission on January 15, 2021. |
|
| January 15, 2021 |
Exhibit 10.11 November 15, 2020 Debra L. Morris Re: Amendment of Executive Severance Agreement Dear Debra: This letter confirms the amendment, as set forth below, of your Executive Severance Agreement, dated March 11, 2013, with Apria Healthcare, Inc., now called Apria Healthcare LLC (the “Agreement”). This letter supersedes that certain letter agreement between you and Apria Healthcare LLC, dated |
|
| January 15, 2021 |
EX-10.23 Exhibit 10.23 INDEPENDENT DIRECTOR AGREEMENT This INDEPENDENT DIRECTOR AGREEMENT (this “Agreement”) is dated December 1, 2019 (the “Effective Date”) by and between APRIA HEALTHCARE GROUP INC., a Delaware corporation (the “Company”), and NORMAN C. PAYSON, M.D., an individual resident of the State of California (the “Director”). WHEREAS, the Director currently serves on the Board of Directo |
|
| January 15, 2021 |
Form of Amended and Restated Certificate of Incorporation of the Registrant EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF APRIA, INC. The present name of the corporation is Apria, Inc. (the “Corporation”). The Corporation was incorporated under the name “Apria, Inc.” by the filing of its original certificate of incorporation (the “Original Certificate of Incorporation”) with the Secretary of State of the State of Delaware on March 22, 2018. This |
|
| January 15, 2021 |
EX-10.34 Exhibit 10.34 CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, APRIA HEALTHCARE GROUP, INC. AND APRIA HEALTHCARE LLC I. PREAMBLE Apria Healthcare Group, Inc., and its wholly owned subsidiary, Apria Healthcare LLC (collectively, Apria) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspecto |
|
| January 15, 2021 |
EX-10.15 Exhibit 10.15 SENIOR VICE PRESIDENT SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 7th day of August, 2014, between Apria Healthcare LLC, a Delaware limited liability company (the “Company”), and Raoul Smyth (the “Executive”). RECITALS A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s c |
|
| January 15, 2021 |
Exhibit 10.16 November 15, 2020 Raoul Smyth Re: Amendment of Senior Vice President Severance Agreement Dear Raoul: This letter confirms the amendment, as set forth below, of your Senior Vice President Severance Agreement, dated August 7, 2014, with Apria Healthcare LLC (as amended, the “Agreement”). This letter supersedes that certain letter agreement between you and Apria Healthcare LLC, dated Ju |
|
| January 15, 2021 |
EX-10.21 Exhibit 10.21 INDEPENDENT DIRECTOR AGREEMENT This INDEPENDENT DIRECTOR AGREEMENT is dated August 15, 2019 (this “Agreement”) by and between APRIA HEALTHCARE GROUP INC., a Delaware corporation (the “Company”), and JOHN R. MURPHY, an individual resident of the State of Florida (the “Director”). WHEREAS, it is anticipated that the Director will be appointed to the Board of Directors of the C |
|
| January 15, 2021 |
EX-10.28 Exhibit 10.28 AMENDMENT NO. 1 to the APRIA HEALTHCARE GROUP INC. DEFERRED COMPENSATION PLAN (Amended and Restated Effective July 23, 2008) Section 11.2 of the Apria Healthcare Group Inc. Deferred Compensation Plan (the “Plan”) provides that any Employer may modify the Plan in whole or in part with respect to that Employer. Accordingly, the Company (as defined under the Plan) hereby amends |
|
| January 15, 2021 |
Exhibit 10.6 Execution Version AMENDMENT NO. 1 TO CREDIT AGREEMENT AMENDMENT NO. 1, dated as of December 11, 2020 (this “Incremental Amendment”) to the Credit Agreement, dated as of June 21, 2019, among Apria Holdings LLC, a Delaware limited liability company (“Holdings”), Apria Healthcare Group Inc., a Delaware corporation (the “Borrower”), the other Guarantors party thereto from time to time, th |
|
| January 15, 2021 |
EX-10.9 Exhibit 10.9 June 27, 2018 Daniel J. Starck Re: Amendment of Executive Employment Agreement Dear Dan: This letter confirms the amendment, as set forth below, of your Executive Employment Agreement, dated March 14, 2012, with Apria Healthcare Group Inc., as previously amended by that certain letter of agreement dated December 5, 2012 (the “Agreement”). In the event that you become entitled |
|
| January 15, 2021 |
Form of Registration Rights Agreement** Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT by and between APRIA, INC. and the other parties hereto Dated as of [], [] TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 SECTION 1.1 Certain Definitions 1 SECTION 1.2 Other Definitional Provisions; Interpretation 5 ARTICLE II REGISTRATION RIGHTS 6 SECTION 2.1 Piggyback Rights 6 SECTION 2.2 Demand Registration 8 SECTION 2.3 Registration Procedures 12 SECT |
|
| January 15, 2021 |
Apria Healthcare Group Inc. Deferred Compensation Plan, effective July 23, 2008 Exhibit 10.27 Apria Healthcare Group Inc. Deferred Compensation Plan Master Plan Document (For Deferrals on or After January 1, 2005) Amended and Restated Effective July 23, 2008 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 3 ARTICLE 2 SELECTION, ENROLLMENT, ELIGIBILITY 11 ARTICLE 3 DEFERRAL COMMITMENTS/COMPANY CONTRIBUTION AMOUNTS/VESTING/CREDITING/TAXES 12 ARTICLE 4 IN-SERVICE DISTRIBUTION/UNFOR |
|
| January 15, 2021 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] January 15, 2021 VIA EDGAR Re: Apria, Inc. Registration Statement on Form S-1 Filed January 15, 2021 CIK No. 0001735803 Ms. Abby Adams Division of Corporation Finance Securities and Exchange Commission 100 F S |
|
| January 15, 2021 |
EX-10.13 Exhibit 10.13 26220 Enterprise Court Lake Forest, California 92630 Tel 949.639.2000 December 20, 2019 Ms. Debra Morris Re: Your Apria Healthcare Group Inc. (“AHG”) Restricted Stock Unit (“RSU”) grant pursuant to letter dated July 24, 2018 (“Grant Letter”) Dear Debby: The purpose of this letter is to evidence our agreement to adjust the terms of your Grant Letter to compensate for the effe |
|
| January 15, 2021 |
EX-10.17 Exhibit 10.17 EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 1st day of April, 2013, between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and Robert P. Walker (the “Executive”). RECITALS A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s contribution to |
|
| January 15, 2021 |
EX-10.5 Exhibit 10.5 Execution Version CREDIT AGREEMENT Dated as of June 21, 2019 among APRIA HOLDINGS LLC, as Holdings, APRIA HEALTHCARE GROUP INC., as the Borrower, THE GUARANTORS PARTY HERETO FROM TIME TO TIME, CITIZENS BANK, N.A., as Administrative Agent, Collateral Agent, Swing Line Lender and an L/C Issuer and THE LENDERS AND L/C ISSUERS PARTY HERETO FROM TIME TO TIME CITIZENS BANK, N.A., FI |
|
| January 4, 2021 |
EX-10.32 12 filename12.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.32 December 1, 2020 Mr. Raoul Smyth Re: Retirement Letter Dear Raoul: This letter agreement reflects the mutually agreed terms of your retirement from Apria Healthcare LLC (the “Company”). |
|
| January 4, 2021 |
EX-10.12 3 filename3.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.12 Execution Version July 24, 2018 Ms. Debra Morris Dear Debby: I am pleased to inform you that you have been selected to receive a transaction-related bonus, as described below. Your continu |
|
| January 4, 2021 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.14 EXECUTION VERSION December 28, 2020 Ms. Debra Morris Re: Your Apria Healthcare Group Inc. (?AHG?) Restricted Stock Unit (?RSU?) grant pursuant to letter dated July 24, 2018, as amended by the letter dated December |
|
| January 4, 2021 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.6 Execution Version AMENDMENT NO. 1 TO CREDIT AGREEMENT AMENDMENT NO. 1, dated as of December 11, 2020 (this ?Incremental Amendment?) to the Credit Agreement, dated as of June 21, 2019, among Apria Holdings LLC, a De |
|
| January 4, 2021 |
Table of Contents Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. As confidentially submitted to the Securities and Exchange Commission on December 31, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM |
|
| January 4, 2021 |
EX-10.13 4 filename4.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.13 26220 Enterprise Court Lake Forest, California 92630 Tel 949.639.2000 December 20, 2019 Ms. Debra Morris Re: Your Apria Healthcare Group Inc. (“AHG”) Restricted Stock Unit (“RSU”) grant pu |
|
| January 4, 2021 |
EX-10.15 6 filename6.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.15 SENIOR VICE PRESIDENT SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 7th day of August, 2014, between Apria Healthcare LLC, a Delaware limited |
|
| January 4, 2021 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.17 EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (this ?Agreement?) is made as of this 1st day of April, 2013, between Apria Healthcare Group Inc., a Delaware corporation (the ?Company?), and Rober |
|
| January 4, 2021 |
EX-10.19 10 filename10.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.19 EXECUTIVE VICE PRESIDENT SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 30th day of April, 2014, between Apria Healthcare Group Inc., a Dela |
|
| January 4, 2021 |
EX-10.20 11 filename11.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.20 December 1, 2020 Mark E. Litkovitz [redacted] Re: Amendment of Executive Vice President Agreement Dear Mark E. Litkovitz: This letter confirms the amendment, as set forth below, of your |
|
| January 4, 2021 |
EX-10.16 7 filename7.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.16 November 15, 2020 Raoul Smyth Re: Amendment of Senior Vice President Severance Agreement Dear Raoul: This letter confirms the amendment, as set forth below, of your Senior Vice President S |
|
| January 4, 2021 |
EX-10.18 9 filename9.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.18 November 15, 2020 Robert P. Walker Re: Amendment of Executive Severance Agreement Dear Robert: This letter confirms the amendment, as set forth below, of your Executive Severance Agreement |
|
| January 4, 2021 |
EX-10.33 13 filename13.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.33 AMENDED AND RESTATED APRIA HEALTHCARE GROUP INC. LONG-TERM INCENTIVE PLAN (2019 – 2021 With Successive Annual Extension Options) 1. Purpose. The purpose of the Apria Healthcare Group Inc |
|
| December 31, 2020 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER (212) 455-7614 E-MAIL ADDRESS [email protected] December 31, 2020 VIA EDGAR Re: Apria, Inc. Draft Registration Statement on Form S-1 Submitted September 21, 2020 CIK No. 0001735803 Ms. Abby Adams Division of Corporation Finance Securities and Exchange Commi |
|
| December 4, 2020 |
EX-10.12 11 filename11.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.12 November 15, 2020 Debra L. Morris Re: Amendment of Executive Severance Agreement Dear Debra: This letter confirms the amendment, as set forth below, of your Executive Severance Agreement |
|
| December 4, 2020 |
EX-10.6 7 filename7.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.6 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”) is entered into by and between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and |
|
| December 4, 2020 |
EX-10.27 Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.27 Apria Healthcare Group Inc. Deferred Compensation Plan Master Plan Document (For Deferrals on or After January 1, 2005) Amended and Restated Effective July 23, 2008 Apria, Inc. has requested confidential |
|
| December 4, 2020 |
EX-10.22 13 filename13.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.22 INDEPENDENT DIRECTOR AGREEMENT This INDEPENDENT DIRECTOR AGREEMENT is dated August 15, 2019 (this “Agreement”) by and between APRIA HEALTHCARE GROUP INC., a Delaware corporation (the “Co |
|
| December 4, 2020 |
EX-10.1 Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.1 STOCKHOLDERS AGREEMENT DATED AS OF [ ], [ ] AMONG APRIA, INC. AND THE OTHER PARTIES HERETO Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursu |
|
| December 4, 2020 |
EX-10.28 16 filename16.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.28 AMENDMENT NO. 1 to the APRIA HEALTHCARE GROUP INC. DEFERRED COMPENSATION PLAN (Amended and Restated Effective July 23, 2008) Section 11.2 of the Apria Healthcare Group Inc. Deferred Comp |
|
| December 4, 2020 |
EX-10.7 8 filename8.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.7 December 5, 2012 Daniel J. Starck 19 Pegasus Dr. Coto De Caza, CA 92679 Re: Amendment of Executive Employment Agreement Dear Dan: This letter confirms the amendment, as set forth below, of y |
|
| December 4, 2020 |
Table of Contents Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. As confidentially submitted to the Securities and Exchange Commission on December 3, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM |
|
| December 4, 2020 |
EX-10.11 Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.11 EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (this “Agreement”) is made as of this 11th day of March, 2013, between Apria Healthcare, Inc., a Delaware corporation (the “Company”), and |
|
| December 4, 2020 |
EX-10.31 Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.31 EXECUTION COPY This TRANSACTION AND MANAGEMENT FEE AGREEMENT (this “Agreement”) is dated as of October 28, 2008 and is between Sky Merger Sub Corporation, a Delaware corporation (together with its success |
|
| December 4, 2020 |
EX-1.1 2 filename2.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 1.1 Apria, Inc. Common Stock, par value $0.01 per share Underwriting Agreement [•], [•] Citigroup Global Markets Inc. Goldman Sachs & Co. LLC As representatives of the several Underwriters named i |
|
| December 4, 2020 |
EX-10.23 14 filename14.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.23 INDEPENDENT DIRECTOR AGREEMENT This INDEPENDENT DIRECTOR AGREEMENT (this “Agreement”) is dated December 1, 2019 (the “Effective Date”) by and between APRIA HEALTHCARE GROUP INC., a Delaw |
|
| December 4, 2020 |
EX-3.1 3 filename3.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF APRIA, INC. The present name of the corporation is Apria, Inc. (the “Corporation”). The Corporation was incorporated under the name “Apria, |
|
| December 4, 2020 |
EX-10.29 17 filename17.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.29 AMENDMENT NO. 2 TO THE APRIA HEALTHCARE GROUP INC. DEFERRED COMPENSATION PLAN The Apria Healthcare Group Inc. Deferred Compensation Plan (“the Plan”) is hereby amended in the following r |
|
| December 4, 2020 |
EX-10.5 6 filename6.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.5 Execution Version CREDIT AGREEMENT Dated as of June 21, 2019 among APRIA HOLDINGS LLC, as Holdings, APRIA HEALTHCARE GROUP INC., as the Borrower, THE GUARANTORS PARTY HERETO FROM TIME TO TIM |
|
| December 4, 2020 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.8 June 27, 2018 Daniel J. Starck Re: Amendment of Executive Employment Agreement Dear Dan: This letter confirms the amendment, as set forth below, of your Executive Employment Agreement, dated March 14, 2012, with Ap |
|
| December 4, 2020 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.30 AMENDMENT NO. 3 TO THE APRIA HEALTHCARE GROUP INC. DEFERRED COMPENSATION PLAN The Apria Healthcare Group Inc. Deferred Compensation Plan (?the Plan?) is, by way of clarification of the administration of the Plan, |
|
| December 4, 2020 |
EX-10.21 12 filename12.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.21 INDEPENDENT DIRECTOR AGREEMENT This INDEPENDENT DIRECTOR AGREEMENT is dated August 15, 2019 (this “Agreement”) by and between APRIA HEALTHCARE GROUP INC., a Delaware corporation (the “Co |
|
| December 4, 2020 |
EX-10.2 5 filename5.htm Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT by and between APRIA, INC. and the other parties hereto Dated as of [], [] Apria, Inc. has requested confidential treatment of this registration statement and a |
|
| December 3, 2020 |
Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] December 3, 2020 VIA EDGAR Re: Apria |
|
| October 16, 2020 |
begin 644 d62545ddrsltr1.pdf M)5!$1BTQ+C8-)>+CS],-"C$@,"!O8FH*/#PO365T861A=&$@,B P(%(O4&%G M97,@,R P(%(O5'EP92]#871A;&]G/CX*96YD;V)J"C(@,"!O8FH*/#PO3&5N M9W1H(#,R-C8O4W5B='EP92]834PO5'EP92]-971A9&%T83X^G)E4WI.5&-Z M:V,Y9"(/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X M.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C8M8S Q-2 X,2XQ-3DX,#DL(#(P M,38O,3$O,3$M,#$Z-#(Z,38@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS M |
|
| October 16, 2020 |
SIMPSON THACHER & BARTLETT LLP 425 LEXINGTON AVENUE NEW YORK, N.Y. 10017-3954 (212) 455-2000 FACSIMILE (212) 455-2502 DIRECT DIAL NUMBER E-MAIL ADDRESS (212) 455-7614 [email protected] October 16, 2020 VIA EDGAR Re: Apria, Inc. Draft Registration Statement on Form S-1 Submitted September 21, 2020 CIK No. 0001735803 Ms. Abby Adams Division of Corporation Finance Securities and Exchange Commis |
|
| September 21, 2020 |
Table of Contents Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. As confidentially submitted to the Securities and Exchange Commission on September 18, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FOR |
|
| September 18, 2020 |
September 18, 2020 VIA EDGAR Re: Apria, Inc. Draft Registration Statement on Form S-1 Submitted August 7, 2020 CIK No. 0001735803 Ms. Abby Adams Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Dear Ms. Adams: On behalf of Apria, Inc. (“Apria”), we hereby transmit via EDGAR for confidential submission with the Securities and Exchange Comm |
|
| August 7, 2020 |
Table of Contents Apria, Inc. has requested confidential treatment of this registration statement and associated correspondence pursuant to Rule 83 of the Securities and Exchange Commission. As confidentially submitted to the Securities and Exchange Commission on August 6, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STAT |
|
| August 6, 2020 |
Simpson Thacher & Bartlett LLP 425 LEXINGTON AVENUE NEW YORK, NY 10017-3954 TELEPHONE: +1-212-455-2000 FACSIMILE: +1-212-455-2502 DIRECT DIAL NUMBER (212) 455-7614 E-MAIL ADDRESS elewandowski@stblaw. |
